Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Undifferentiated embryonic cell transcription factor 1 (UTF1) is a chromatin-associated transcription factor highly expressed in embryonic stem (ES) cells, embryonic carcinoma (EC) cells, and germ line tissues but absent in mature somatic tissues[1][2]. It acts primarily as a transcriptional repressor and coactivator, displaying both repressive and coactivation functions depending on context. UTF1 contains a Myb/SANT domain and a leucine zipper motif, both essential for its association with chromatin and regulatory activity[1][2]. Functionally, UTF1 plays a crucial role in promoting and initiating the differentiation of ES cells, while its knockdown delays or blocks differentiation without affecting self-renewal[1]. Its nuclear localization, strong DNA association, and dynamic chromatin-binding properties are reminiscent of core histones, indicating a possible architectural role in chromatin structure during early development[1]. While UTF1 is a key pluripotency marker and regulator, there are currently no known drugs or direct therapeutic strategies targeting it, nor documented associations with specific human diseases[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Undifferentiated embryonic cell transcription factor 1 (UTF1).